Company Analysis

CG Oncology, Inc. (CGON)

Nasdaq: CGON · Biological Products, (No Diagnostic Substances) · Irvine, CA · filing with the SEC since 2023
Grade5.6
◀ Past 5.4● Present 5.7▶ Future 5.6
3 est.

Who runs CG Oncology, Inc.

Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filed
Chief executive, as filed
Kuan Arthur
Chief Executive Officer. First filing Jan 2024, latest Apr 16, 2026, 0 filings in all.
Officers reporting now
7
of 14 people with a filing in the last fifteen months
Directors reporting now
7
15 people on the record since 2024
Officerssales are open-market, Oct 19, 2025 to Oct 19, 2026
NameTitle as filedFirst filingLatest filingSales, 12 months
Kalofonos IsabelChief Commercial OfficerOct 2026Oct 19, 2026none
Kuan ArthurChief Executive OfficerJan 2024Apr 16, 2026none
Bellete AmbawPresident and COOJan 2024Apr 16, 2026none
Detore James M.Chief Financial OfficerNov 2025Apr 16, 2026none
Kasturi VijayChief Medical OfficerJan 2024Apr 16, 2026none
Patterson Joshua F.General Counsel and Chief Compliance OfficerMay 2024Apr 16, 2026none
Lapetina BobInterim Principal Financial and Accounting OfficerAug 2025Aug 6, 2025none
Directorssales are open-market, Oct 19, 2025 to Oct 19, 2026
NameRoleFirst filingLatest filingSales, 12 months
Post Leonard EdirectorJan 2024Oct 19, 20269 · $1.1M
Mulay JamesdirectorJan 2024Jul 14, 20268 · $3.8M
Liu Brian Guan-ChyundirectorJan 2024Jun 29, 2026none
Graf Susan EdirectorJan 2024Jun 5, 2026none
Rossi ChristinadirectorNov 2025Jun 5, 2026none
Tong Victor Edward JrdirectorJan 2024Jun 5, 2026none
Song Hong FangdirectorJan 2024Sep 4, 2025none
Earlier names on the record14, newest filing first

A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.

SI Assistanton CGON · research, not advice